Bradford D. Dahms

Chief Financial Officer

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

RNAC

CFO

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2021	Cartesian Therapeutics, Inc. (RNAC)	Chief Financial Officer	$183,206	—	$154,733	$526,588	—	$3,526	$868,053
2020	Cartesian Therapeutics, Inc. (RNAC)	Chief Financial Officer	$370,577	$25,000	—	$323,644	$172,500	$67,635	$959,356
2019	Cartesian Therapeutics, Inc. (RNAC)	Chief Financial Officer	$113,077	$50,000	—	$499,753	$60,000	$45,774	$768,604

No earnings-call appearances or filed executive changes recorded yet.